Literature DB >> 164529

Dopaminergic mechanisms of opiate actions in brain.

E Eidelberg, R Erspamer.   

Abstract

We have studied the interactions between morphine and a dopamine-blocking agent (haloperidol) and a dopamine precursor, L-3,4-dihydroxyphenylalanine (L-dopa). We found that haloperidol potentiated morphine-induced analgesia and enhanced morphine tolerance. Morphine-tolerant mice exhibited enhanced sensitivity to the locomotor excitatory actions of L-dopa. We propose that morphine exerts some of its central nervous actions by first interfering with dopamine-mediated synaptic transmission and then initiating compensatory changes that superficially resemble denervation supersensitivity. These compensatory changes may underlie the excitatory actions of morphine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164529

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Time-dependent disruptive effects of apomorphine and alpha-methyl-p-tyrosine on development of morphine tolerance.

Authors:  R P Kesner; D J Priano; T Gold
Journal:  Psychopharmacology (Berl)       Date:  1977-12-19       Impact factor: 4.530

Review 3.  Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Authors:  Noha F Minshawi; Sarah Hurwitz; Danielle Morriss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2015-06

4.  Naloxone-precipitated withdrawal reveals sensitization to neurotransmitters in morphine tolerant/dependent rats.

Authors:  R Schulz; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

Review 5.  Comparative aspects of opioid-dopamine interaction.

Authors:  G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1982-09       Impact factor: 5.046

6.  Evidence for increased apomorphine-sensitive dopaminergic effects after acute treatment with morphine.

Authors:  J Scheel-Krüger; K Golembiowska; E Mogilnicka
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

7.  Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig.

Authors:  R D Eibergen; K R Carlson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

8.  Galanin protects against behavioral and neurochemical correlates of opiate reward.

Authors:  Jessica J Hawes; Darlene H Brunzell; Roopashree Narasimhaiah; Ulo Langel; David Wynick; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

9.  Antagonism of morphine-induced central stimulation in mice by small doses of catecholamine-receptor agonists.

Authors:  U Strömbom; T H Svensson
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

10.  Characterization of the dopamine stimulated adenylate cyclase in the pedal ganglia of Mytilus edulis: interactions with etorphine, beta-endorphin, DALA, and methionine enkephalin.

Authors:  G B Stefano; E J Catapane; R M Kream
Journal:  Cell Mol Neurobiol       Date:  1981-03       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.